Skip to content

Press Releases

Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.

Medifast Posts Record Revenues YTD Up 125% to 19.5 Million and Quarterly, Up 126% to 6.8 Million
`Test TV Commercial a Whopping Success'
PRNewswire-FirstCall
OWINGS MILLS, Md.

Medifast, Inc. announced today that based on preliminary figures, the company has posted record revenues for the quarter ending September 30, 2003, and the month of September. Medifast attributes the record revenues to its "dynamic business model." According to Medifast, third quarter unaudited revenues soared to $6.8 million in 2003 as against $3 million in 2002, a $3.8 million or 126% increase over last year. September 2003's revenues increased by $1.2 million or 100% over the revenues of September 2002. Year to date, the company generated $19.5 million in revenues (unaudited) as against $8.7 million in 2002; a $10.8 million or 125% increase on a year to date basis.

Medifast increased its advertising program to support its customer base and its Take Shape for Life health advisor network posted record revenues in September 2003 and increased the number of health advisor network distributors by over 15% during the month.

Chief Executive Officer, Bradley T. MacDonald was pleased to announce that, "The two week test of the company's TV commercial was a whopping success." He said that the Company will announce its 2004 annual and quarterly forecast on December 11, 2003 at 4:30PM at the New York Athletic Club. The Medifast Marketing and Sales team combined with Brennan Responses Production and infrastructure development to carry forward the company's advertising objectives.

This release contains forward-looking statements, which may involve known, and unknown risks, uncertainties and other factors that may cause Medifast's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Medifast cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectation on this date.

SOURCE: Medifast, Inc.

CONTACT: Jeremy Hunt, Public & Investor Relations Specialist, Medifast,
+1-410-504-8196; or Ken Sgro, CEOcast, Inc. for Medifast, +1-212-732-4300